Nesrin Özören
From Wikipedia, the free encyclopedia
University of Pennsylvania College of Arts & Sciences (PhD)
Nesrin Özören | |
|---|---|
| Born | July 25, 1972 Paisievo, Silistra Province, Bulgaria |
| Alma mater | Boğaziçi University (BS) University of Pennsylvania College of Arts & Sciences (PhD) |
| Scientific career | |
| Fields | Molecular biology |
| Institutions | Boğaziçi University |
| Thesis | Involvement of TRAIL-Death Receptors in Human Tumorigenesis and Mechanisms of TRAIL-Induced Apoptosis Signaling (2002) |
| Doctoral advisor | Wafik El-Deiry |
Nesrin Özören (born July 25, 1972), is a Turkish molecular biologist researching vaccines, apoptosis, innate immune signaling, Behçet's disease, and melanomas. She is a professor at Boğaziçi University.
Nesrin Özören was born in a family of Bulgarian Turks on July 25, 1972, in the Paisievo in Silistra Province, Bulgaria. In 1995, she completed a B.S. in the department of molecular biology and genetics at Boğaziçi University where she graduated second in her class.[1][2]
In 2002, Özören earned a Ph.D. in the department of biology at the University of Pennsylvania College of Arts & Sciences. Her thesis was titled, Involvement of TRAIL-Death Receptors in Human Tumorigenesis and Mechanisms of TRAIL-Induced Apoptosis Signaling. Her doctoral advisor was Wafik El-Deiry.[1][3]
From July 2002 to June 2005, Özören was a postdoctoral researcher in the department of pathology at the University of Michigan. Her advisor was Gabriel Núñez.[1]
Career and research
In August 2005, Özören joined the faculty at the Boğaziçi University's department of molecular biology and genetics as an assistant professor. She was promoted to associate professor in 2008 and professor in 2015.[1]
Özören is a founding member of the Cell Death Research Society of Turkey.[1]
Özören researches vaccines, apoptosis, innate immune signaling, Behçet's disease, and melanomas.[1] In 2018, her invention, "Microsphere Technology for Durable Vaccine Carrying Proteins" became the first triadic patent in the field of biotechnology in Turkey.[4] In 2020, Özören is leading a team to develop a COVID-19 vaccine based on her patented technology.[5][6]
